❉ Buffybot wonderful businesses, fair prices

← back

HSIC Henry Schein

healthcare · 2026-09-17

N/A
too hard · 56
Owner-earnings value$72.25
Price$86.77
Margin of safety -16.7%

Quality gate · 56/100

Returns on capital 6.0/30
Consistency 19.5/22
Margins / pricing power 9.3/16
Balance sheet 5.4/16
Cash conversion 10/10
Capital allocation 6/6

⚠ sub-hurdle returns (median roic 8% < 9%)

Median ROIC8.2%
Gross margin31.3%
Net debt / EBITDA3.2x
FCF conversion113%
Share count / yr-4.2%
Profitable years4/4

Moat & management

Owner-earnings inputs

Owner earnings (TTM)513.00M
Owner-earnings yield5.2%
Free-cash-flow yield5.2%
Growth used (normalized)1.4%
Market-implied growth (reverse DCF)5.8%
Terminal growth3.0%
Discount rate (hurdle)9.0%

Projected owner earnings

YrOwner earningsGrowthPV
1520.16M 1.4%477.21M
2528.35M 1.6%444.70M
3537.61M 1.8%415.13M
4547.98M 1.9%388.21M
5559.54M 2.1%363.66M
6572.34M 2.3%341.27M
7586.45M 2.5%320.81M
8601.95M 2.6%302.10M
9618.93M 2.8%284.97M
10637.50M 3.0%269.29M

Recent news

score · 8 articles

  • What Makes Henry Schein (HSIC) a New Buy Stock
  • HSIC or SAUHY: Which Is the Better Value Stock Right Now?
  • Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why
  • Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?
  • Is Henry Schein (HSIC) Stock Undervalued Right Now?
  • Henry Schein (HSIC) Looks Modestly Undervalued, Is More Upside Still Available?
  • Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis
  • HSIC vs. SAUHY: Which Stock Is the Better Value Option?

⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Price pays for ~6%/yr owner-earnings growth over 10y (reverse DCF); model credits 1%.

History

DateQualityPriceValueMoSRating
2026-09-17 56 $86.77 $72.25 -16.7% N/A
2026-07-29 56 $85.71 $55.07 -35.8% N/A
2026-07-02 56 $84.52 $55.07 -34.8% N/A
2026-06-25 56 $82.82 $55.07 -33.5% N/A
2026-06-23 56 $80.10 $55.07 -31.3% N/A